Long-Term Safety and Efficacy of rFIXFc in the Prevention and Treatment of Bleeding Episodes in Previously Treated Participants With Hemophilia B

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

December 8, 2011

Primary Completion Date

October 31, 2017

Study Completion Date

October 31, 2017

Conditions
Severe Hemophilia B
Interventions
BIOLOGICAL

rFIXFc

Administered as specified in the treatment arm.

Trial Locations (49)

1200

Research Site, Brussels

2193

Research Site, Johannesburg

3000

Research Site, Leuven

3052

Research site, Parkville

5000

Research Site, Adelaide

6008

Research Site, Perth

6150

Research site, Murdoch

7925

Research Site, Cape Town

13385

Research Site, Marseille

15213

Research Site, Pittsburgh

17176

Research Site, Stockholm

20122

Research Site, Milan

20502

Research Site, Malmo

30322

Research Site, Atlanta

46260

Research Site, Indianapolis

48823

Research Site, East Lansing

50134

Research Site, Florence

53127

Research Site, Bonn

70112

Research Site, New Orleans

80045

Research Site, Aurora

85016

Research Site, Phoenix

95817

Research Site, Sacramento

96826

Research Site, Honolulu

98104

Research Site, Seattle

100005

Research Site, Beijing

200025

Research Site, Shanghai

300020

Research Site, Tianjing

411004

Research Site, Pune

510515

Research Site, Guangzhou

560034

Research Site, Bangalore

632004

Research Site, Vellore

13083-878

Research Site, Campinas

M5B 1W8

Research Site, Toronto

H3T 1C5

Research Site, Montreal

Unknown

Research Site, Hong Kong

Research site, Hong Kong

D12 N512

Research Site, Dublin

466-8550

Research Site, Nagoya

807-8555

Research Site, Kitakyushu

216-8511

Research Site, Kawasaki

634-8522

Research Site, Kashihara-shi

160-0023

Research Site, Shinjuku-ku

167-8515

Research Site, Tokyo

3584 CX

Research Site, Utrecht

93-510

Research Site, Lodz

CB2 0QQ

Research Site, Cambridge

E1 1BB

Research Site, London

SE1 7EH

Research site, London

RG24 9NA

Research Site, Basingstoke

Sponsors
All Listed Sponsors
lead

Bioverativ Therapeutics Inc.

INDUSTRY